TET3 is a common epigenetic immunomodulator of pathogenic macrophages

Journal:

Journal of Clinical Investigation

Published:

2025-08-12

DOI:

10.1172/jci194879

Affiliations:

14

Authors:

18

Go to article

Institutions	Authors	Share
Yale University, United States of America (USA)	10.000000 10.000000	0.56
Shengjing Hospital of China Medical University, China	2.500000	0.14
UConn Health, United States of America (USA)	2.000000	0.11
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China	1.500000	0.08
University of Virginia (UVA), United States of America (USA)	1.000000	0.06
Jinshazhou Hospital of Guangzhou University of Chinese Medicine, China	0.500000	0.03
Drum Tower Hospital, China	0.500000	0.03

Interested in Immunology?